ATE374197T1 - Indolderivate zur behandlung von erkrankungen des zentralnervensystems - Google Patents

Indolderivate zur behandlung von erkrankungen des zentralnervensystems

Info

Publication number: ATE374197T1
Authority: AT; Austria
Prior art keywords: treatment; nervous system; central nervous; system diseases; indole derivatives
Prior art date: 2000-06-14

Application number

AT04012325T

Other languages

English (en)

Inventor

Benny Bang-Andersen

Jan Kehler

Jacob Felding

Kim Andersen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-14

Filing date

2001-06-13

Publication date

2007-10-15

2001-06-13 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2007-10-15 Application granted granted Critical

2007-10-15 Publication of ATE374197T1 publication Critical patent/ATE374197T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT04012325T 2000-06-14 2001-06-13 Indolderivate zur behandlung von erkrankungen des zentralnervensystems ATE374197T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200000919		2000-06-14
US21244500P	2000-06-16	2000-06-16

Publications (1)

Publication Number	Publication Date
ATE374197T1 true ATE374197T1 (de)	2007-10-15

Family

ID=26068835

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT04012325T ATE374197T1 (de)	2000-06-14	2001-06-13	Indolderivate zur behandlung von erkrankungen des zentralnervensystems
AT01940240T ATE297391T1 (de)	2000-06-14	2001-06-13	Indolderivate zum gebrauch in der behandlung von zns-störungen

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT01940240T ATE297391T1 (de)	2000-06-14	2001-06-13	Indolderivate zum gebrauch in der behandlung von zns-störungen

Country Status (20)

Country	Link
US (2)	US6890916B2 (de)
EP (1)	EP1294710B1 (de)
JP (1)	JP2004503550A (de)
KR (1)	KR20030007967A (de)
AR (1)	AR028685A1 (de)
AT (2)	ATE374197T1 (de)
AU (2)	AU7388101A (de)
BG (1)	BG107449A (de)
CA (1)	CA2411412C (de)
CZ (1)	CZ200335A3 (de)
DE (2)	DE60111379T2 (de)
DK (1)	DK1468996T3 (de)
ES (2)	ES2243508T3 (de)
HR (1)	HRP20021008A2 (de)
HU (1)	HUP0301735A2 (de)
NO (1)	NO323236B1 (de)
NZ (1)	NZ523076A (de)
PT (2)	PT1294710E (de)
SG (1)	SG148840A1 (de)
WO (1)	WO2001096328A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2165274B1 (es) *	1999-06-04	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
SI1294710T1 (en) *	2000-06-14	2005-10-31	H. Lundbeck A/S	Indole derivatives useful for the treatment of cns disorders
ES2172436B1 (es)	2000-10-31	2004-01-16	Almirall Prodesfarma Sa	Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
AU2003236207A1 (en) *	2002-05-31	2003-12-19	H. Lundbeck A/S	The hydrochloride of (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole
AU2003257407A1 (en) *	2002-08-29	2004-03-19	H. Lundbeck A/S	S-(+)-3-{1-(2-(2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof
GB0306604D0 (en) *	2003-03-21	2003-04-30	Curidium Ltd	Second medical use
WO2004108671A1 (en) *	2003-06-06	2004-12-16	Suven Life Sciences Limited	Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them
GB0708186D0 (en) *	2007-04-27	2007-06-06	Merck Sharp & Dohme	Therapeutic compounds
SE531698C2 (sv)	2007-07-12	2009-07-07	Respiratorius Ab	Nya bronkdilaterande a,b-omättade amider

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9202915D0 (en) *	1992-02-12	1992-03-25	Wellcome Found	Chemical compounds
ZA9711376B (en) *	1996-12-20	1998-07-21	Lundbeck & Co As H	Indole or dihydroindole derivatives
EP0897921A1 (de) *	1997-08-22	1999-02-24	Eli Lilly And Company Limited	Benzothiadiazinyl-indolderivate und ihre Verwendung als Serotoninrezeptor-liganden
GB9718833D0 (en) *	1997-09-04	1997-11-12	Merck Sharp & Dohme	Therapeutic agents
GB9810886D0 (en) *	1998-05-13	1998-07-22	Lilly Industries Ltd	Pharmaceutical compounds
GB9825413D0 (en) *	1998-11-19	1999-01-13	Lilly Co Eli	Pharmaceutical compounds
AU2494300A (en) *	1999-01-07	2000-07-24	American Home Products Corporation	3,4-dihydro-2h-benzo(1,4)oxazine derivatives
JP2002544223A (ja) *	1999-05-12	2002-12-24	ソルベイ・フアーマシユーチカルズ・ベー・ブイ	精神病性障害の治療方法
EP1106605A4 (de) *	1999-06-24	2005-12-07	Toray Industries	Antagonisten des andrenergen-alpha1b-rezeptors
GB2362381A (en) *	2000-05-18	2001-11-21	Lilly Co Eli	Pharmaceutically active indolyl-piperidines

2001
- 2001-06-06 AR ARP010102697A patent/AR028685A1/es not_active Application Discontinuation
- 2001-06-13 PT PT01940240T patent/PT1294710E/pt unknown
- 2001-06-13 SG SG200501564-9A patent/SG148840A1/en unknown
- 2001-06-13 DK DK04012325T patent/DK1468996T3/da active
- 2001-06-13 DE DE60111379T patent/DE60111379T2/de not_active Expired - Fee Related
- 2001-06-13 NZ NZ523076A patent/NZ523076A/en unknown
- 2001-06-13 AT AT04012325T patent/ATE374197T1/de not_active IP Right Cessation
- 2001-06-13 WO PCT/DK2001/000406 patent/WO2001096328A1/en active IP Right Grant
- 2001-06-13 KR KR1020027017034A patent/KR20030007967A/ko active IP Right Grant
- 2001-06-13 CZ CZ200335A patent/CZ200335A3/cs unknown
- 2001-06-13 AT AT01940240T patent/ATE297391T1/de not_active IP Right Cessation
- 2001-06-13 PT PT04012325T patent/PT1468996E/pt unknown
- 2001-06-13 DE DE60130691T patent/DE60130691T2/de not_active Expired - Fee Related
- 2001-06-13 HU HU0301735A patent/HUP0301735A2/hu unknown
- 2001-06-13 AU AU7388101A patent/AU7388101A/xx active Pending
- 2001-06-13 JP JP2002510470A patent/JP2004503550A/ja active Pending
- 2001-06-13 CA CA002411412A patent/CA2411412C/en not_active Expired - Fee Related
- 2001-06-13 EP EP01940240A patent/EP1294710B1/de not_active Expired - Lifetime
- 2001-06-13 AU AU2001273881A patent/AU2001273881B8/en not_active Ceased
- 2001-06-13 ES ES01940240T patent/ES2243508T3/es not_active Expired - Lifetime
- 2001-06-13 ES ES04012325T patent/ES2290587T3/es not_active Expired - Lifetime
2002
- 2002-12-09 US US10/315,927 patent/US6890916B2/en not_active Expired - Fee Related
- 2002-12-13 NO NO20026005A patent/NO323236B1/no unknown
- 2002-12-17 HR HR20021008A patent/HRP20021008A2/hr not_active Application Discontinuation
2003
- 2003-01-08 BG BG107449A patent/BG107449A/bg unknown
2005
- 2005-03-03 US US11/073,497 patent/US7276508B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20030191133A1 (en)	2003-10-09
JP2004503550A (ja)	2004-02-05
HRP20021008A2 (en)	2005-02-28
US6890916B2 (en)	2005-05-10
ES2243508T3 (es)	2005-12-01
CZ200335A3 (cs)	2003-04-16
AU2001273881B8 (en)	2006-02-09
PT1294710E (pt)	2005-10-31
PT1468996E (pt)	2007-11-28
CA2411412C (en)	2008-09-02
ATE297391T1 (de)	2005-06-15
NO323236B1 (no)	2007-02-05
HUP0301735A2 (hu)	2003-08-28
NO20026005D0 (no)	2002-12-13
WO2001096328A1 (en)	2001-12-20
AU2001273881B2 (en)	2005-12-22
NZ523076A (en)	2004-09-24
DE60130691T2 (de)	2008-07-17
DE60130691D1 (de)	2007-11-08
AR028685A1 (es)	2003-05-21
DE60111379T2 (de)	2006-03-16
BG107449A (bg)	2003-09-30
US7276508B2 (en)	2007-10-02
EP1294710B1 (de)	2005-06-08
DK1468996T3 (da)	2008-01-07
US20050176729A1 (en)	2005-08-11
DE60111379D1 (de)	2005-07-14
CA2411412A1 (en)	2001-12-20
NO20026005L (no)	2002-12-13
SG148840A1 (en)	2009-01-29
ES2290587T3 (es)	2008-02-16
EP1294710A1 (de)	2003-03-26
AU7388101A (en)	2001-12-24
KR20030007967A (ko)	2003-01-23

Publication	Publication Date	Title
DE60124302D1 (de)	2006-12-14	Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE269303T1 (de)	2004-07-15	Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60019556D1 (de)	2005-05-25	2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE275145T1 (de)	2004-09-15	Chinazolinderivate zur behandlung von tumoren
ATE425965T1 (de)	2009-04-15	1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE308997T1 (de)	2005-11-15	Mittel zur behandlung von erkrankungen der speiseröhre
DE69925571D1 (de)	2005-07-07	Sulphonamid-derivate zur behandlung von störungen des zentralnervensystems
DE69922914D1 (de)	2005-02-03	Stimulationssystem zur Behandlung von Erkrankungen bezüglich des Magenspeiseröhrenreflux
DE60142473D1 (de)	2010-08-12	Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
DE60019555D1 (de)	2005-05-25	2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE310566T1 (de)	2005-12-15	5ht2-agoniste zur behandlung des glaukoms
DE69936335D1 (de)	2007-08-02	Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
ATE451921T1 (de)	2010-01-15	Phenylindole zur behandlung von hiv
DE60312736D1 (de)	2007-05-03	1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60204466D1 (de)	2005-07-07	Integrinhemmer zur behandlung von augenkrankheiten
DE50013843D1 (de)	2007-01-18	Arzneimittel zur behandlung von darmerkrankungen
ATE374197T1 (de)	2007-10-15	Indolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60016047D1 (de)	2004-12-23	Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60021252D1 (de)	2005-08-18	Antikonvulsiva zur behandlung von autismus
DE60018200D1 (de)	2005-03-24	Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
ATE330596T1 (de)	2006-07-15	Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE230741T1 (de)	2003-01-15	3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
PT1305307E (pt)	2004-09-30	Derivados de indole eficazes no tratamento de doencas do sistema nervoso central
DE60005685D1 (de)	2003-11-06	Oxazinocarbazole zur behandlung von cns-erkrankungen
DE60020833D1 (de)	2005-07-21	Melatonin zur behandlung von paralysen ausgelöst durch hirnschlag

Legal Events

Date	Code	Title	Description
2007-12-15	UEP	Publication of translation of european patent specification	Ref document number: 1468996 Country of ref document: EP
2010-03-15	REN	Ceased due to non-payment of the annual fee

Date

Code

Title

Description

2007-12-15

UEP

Publication of translation of european patent specification

Ref document number: 1468996

Country of ref document: EP

2010-03-15

REN

Ceased due to non-payment of the annual fee